What is CAR T-cell therapy?
CAR T-cell therapy is a type of cancer therapy that uses a patient’s own modified white blood cells to kill cancer cells.
What types of cancer does CAR T-cell therapy treat?
Two CAR T cell therapies are currently available – axicabtagene ciloleucel (Yescarta®) and tisagenlecleucel (Kymriah®).
Yescarta® has been approved by the Food and Drug Administration (FDA) to treat adults with large B-cell non-Hodgkin lymphomas (including diffuse large B-cell lymphoma –DLBCL) whose cancer has returned or has not been fully successfully treated with at least two prior treatment regimens. Lymphoma is a cancer of the body’s immune system. Kymriah® is approved for children and adults up to age 25 with advanced acute lymphoblastic leukemia (cancer of the body’s blood-forming tissues).